Aptevo Therapeutics Inc. · NASDAQ:APVO
Aptevo Therapeutics Inc. shareholders
As of Sep 30, 2026, 10 institutions reported holding Aptevo Therapeutics Inc., 9.8% of its shares. Largest: Sabby Management, LLC, Hudson Bay Capital Management LP and Citadel. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Aptevo Therapeutics Inc. | Change | Filed |
|---|---|---|---|---|
| Sabby Management, LLC | 233K | 6.7% | new | Nov 13, 2026 |
| Hudson Bay Capital Management LP | 40,700 | 1.2% | new | Nov 13, 2026 |
| Citadel | 25,171 | 0.73% | new | Nov 16, 2026 |
| Gsa Capital Partners LLP | 21,539 | 0.62% | no change | Nov 16, 2026 |
| Vanguard | 16,855 | 0.49% | no change | Nov 13, 2026 |
| Tower Research Capital LLC (TRC) | 1,911 | 0.06% | new | Nov 16, 2026 |
| Osaic Holdings, Inc. | 360 | 0.01% | no change | Nov 12, 2026 |
| SBI Securities Co., Ltd. | 105 | <0.01% | −4 | Oct 21, 2026 |
| Caitong International Asset Management Co., Ltd | 3 | <0.01% | new | Oct 29, 2026 |
| Danske Bank A/S | 1 | <0.01% | no change | Nov 9, 2026 |